Oscar Health, Inc. (OSCR) stock
OSCRNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3026% above fair value
$29.84−1.49 (-4.76%)
Close on Nov 17, 2026Market cap $9.21BP/E 21.3Yield –
Oscar Health cash
Cash and short-term investments held at the end of each period.
Oscar Health's cash was $8.56B at Jun 30, 2026. For fiscal 2025 it was $3.99B, up 83.4% from the year before. The highest annual figure on record is $3.99B in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.99B | +83.4% |
| FY2024 | Dec 31, 2024 | $2.18B | -15.0% |
| FY2023 | Dec 31, 2023 | $2.56B | -14.0% |
| FY2022 | Dec 31, 2022 | $2.98B | +73.9% |
| FY2021 | Dec 31, 2021 | $1.71B | +41.6% |
| FY2020 | Dec 31, 2020 | $1.21B | +242.3% |
| FY2019 | Dec 31, 2019 | $353.38M | -4.6% |
| FY2018 | Dec 31, 2018 | $370.36M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $8.56B | +141.9% |
| Q1 FY2026 | Mar 31, 2026 | $6.80B | +127.6% |
| Q4 FY2025 | Dec 31, 2025 | $3.99B | +83.4% |
| Q3 FY2025 | Sep 30, 2025 | $3.04B | +77.6% |
| Q2 FY2025 | Jun 30, 2025 | $3.54B | +34.4% |
| Q1 FY2025 | Mar 31, 2025 | $2.99B | +5.0% |
| Q4 FY2024 | Dec 31, 2024 | $2.18B | -15.0% |
| Q3 FY2024 | Sep 30, 2024 | $1.71B | -30.0% |
| Q2 FY2024 | Jun 30, 2024 | $2.63B | -26.4% |
| Q1 FY2024 | Mar 31, 2024 | $2.85B | -17.1% |
| Q4 FY2023 | Dec 31, 2023 | $2.56B | -14.0% |
| Q3 FY2023 | Sep 30, 2023 | $2.44B | -13.7% |
| Q2 FY2023 | Jun 30, 2023 | $3.58B | +9.4% |
| Q1 FY2023 | Mar 31, 2023 | $3.43B | +19.3% |
| Q4 FY2022 | Dec 31, 2022 | $2.98B | +73.9% |
| Q3 FY2022 | Sep 30, 2022 | $2.83B | +70.2% |
| Q2 FY2022 | Jun 30, 2022 | $3.27B | +43.1% |
| Q1 FY2022 | Mar 31, 2022 | $2.88B | +6.2% |
| Q4 FY2021 | Dec 31, 2021 | $1.71B | +41.6% |
| Q3 FY2021 | Sep 30, 2021 | $1.66B | +393.1% |
| Q2 FY2021 | Jun 30, 2021 | $2.29B | +131.3% |
| Q1 FY2021 | Mar 31, 2021 | $2.71B | +451.2% |
| Q4 FY2020 | Dec 31, 2020 | $1.21B | +242.3% |
| Q3 FY2020 | Sep 30, 2020 | $337.41M | -8.9% |
| Q2 FY2020 | Jun 30, 2020 | $988.53M | – |
| Q1 FY2020 | Mar 31, 2020 | $491.71M | – |
| Q4 FY2019 | Dec 31, 2019 | $353.38M | – |
| Q4 FY2018 | Dec 31, 2018 | $370.36M | – |
See a number that looks wrong?